These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10953633)

  • 1. [Metabolic and hormonal links in obese individuals with and without symptoms of syndrome X].
    Nedĕlníková K; Svacina S; Matoulek M; Sonka J
    Sb Lek; 2000; 101(1):67-9. PubMed ID: 10953633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy.
    Valerio G; Licenziati MR; Iannuzzi A; Franzese A; Siani P; Riccardi G; Rubba P
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):279-84. PubMed ID: 16679220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analysis of metabolic syndrome components in obese women.
    Lafortuna CL; Adorni F; Agosti F; Sartorio A
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
    Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin resistance. A syndrome responsible for various cardiovascular diseases].
    Golay A
    Schweiz Rundsch Med Prax; 1992 Jan; 81(3):45-8. PubMed ID: 1733002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatness, lipids, insulin sensitivity, and life style of children from high and low risk families.
    Basit A; Hakeem R; Hydrie MZ; Ahmedani MY; Masood Q
    J Ayub Med Coll Abbottabad; 2003; 15(3):6-9. PubMed ID: 14727329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is visceral obesity the cause of the metabolic syndrome?
    Després JP
    Ann Med; 2006; 38(1):52-63. PubMed ID: 16448989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic risk in obese and in diabetic children.
    Popa I; Drăgan M; Georgescu L; Deutsch G; Oţetea G; Schmidt-Georoceanu A; Man I; Grigoriţa M; Beligan C; Popa Z
    Endocrinologie; 1984; 22(1):61-70. PubMed ID: 6369504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep apnea is a manifestation of the metabolic syndrome.
    Vgontzas AN; Bixler EO; Chrousos GP
    Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome--from insulin resistance to obesity and diabetes.
    Gallagher EJ; LeRoith D; Karnieli E
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):559-79, vii. PubMed ID: 18775352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome.
    Brambilla P; Lissau I; Flodmark CE; Moreno LA; Widhalm K; Wabitsch M; Pietrobelli A
    Int J Obes (Lond); 2007 Apr; 31(4):591-600. PubMed ID: 17384660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass.
    Coppini LZ; Bertevello PL; Gama-Rodrigues J; Waitzberg DL
    Obes Surg; 2006 Nov; 16(11):1520-5. PubMed ID: 17132419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse idiopathic skeletal hyperostosis in diabetes mellitus, impaired glucose tolerance and obesity.
    Coaccioli S; Fatati G; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
    Panminerva Med; 2000 Dec; 42(4):247-51. PubMed ID: 11294086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.